Product Information
PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $2.8472 per EA under NDC 43598062730. Its NADAC has been published 55 times since Sep 17, 2025.
FDA first approved this application on Jun 12, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15; 92 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598062730
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA208175FDA Approved
6/12/2025
TE Code
AB
On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE has been published 55 times since Sep 17, 2025, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8472 per EA |
|---|---|
| All-time high | $3.7531 (Mar 11, 2026) |
| All-time low | $2.8472 (Sep 23, 2026) |
| 52-week high | $3.7531 |
| 52-week low | $2.8472 |
| Median price | $3.4119 |
| Average price | $3.4292 |
| Largest weekly change | -10.6% (Sep 23, 2026) |
| Weeks tracked | 55 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Phentermine and Topiramate Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phentermine and Topiramate Extended-Release market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sympathomimetic Amine Anorectic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $2.8472 per EA (NDC 43598062730), effective Sep 30, 2026.
How has the price of PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE has declined 9.4%. It has been tracked across 55 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
Since Sep 17, 2025, the NADAC for PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE has ranged from a low of $2.8472 (Sep 23, 2026) to a high of $3.7531 (Mar 11, 2026), with a median of $3.4119 per EA.
Are there cheaper alternatives to PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE?
PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE (NDC 43598062730) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.